Results 51 to 60 of about 202,254 (242)

Глобализация как фактор радикализации трансформации приоритетов социально-экономического развития в посттранзитивних экономиках [PDF]

open access: yes, 2011
Expression of the for khead transcription factor FOXP1 is essential for early B-cell development, whereas down regulation ofFOXP1at the germinal center (GC) stage is required for GC B-cell function. Aberrantly high FOXP1 expression is frequently observed
Banham   +63 more
core   +2 more sources

Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas

open access: yesHaematologica, 2008
Background Follicular lymphomas are currently subdivided into grades I, II, IIIa and IIIb. This distinction is, however, questioned.Design and Methods We studied the gene expression profile of 43 follicular lymphomas, 50 B-cell non-Hodgkin’s lymphomas of
Pier Paolo Piccaluga   +11 more
doaj   +1 more source

Spinal cord compression by B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma in a patient seropositive for human immunodeficiency virus: a case report [PDF]

open access: yes, 2014
INTRODUCTION: Although non-Hodgkin’s lymphoma is one of the most common and frequently fatal of the acquired immune deficiency syndrome-defining illnesses, survival has improved significantly since the introduction of antiretroviral therapy.
Jun-Yeong Seo   +4 more
core   +1 more source

Overexpression of FoxM1 offers a promising therapeutic target in diffuse large B-cell lymphoma

open access: yesHaematologica, 2012
Background FoxM1 has been shown to play a critical role in the pathogenesis of various epithelial malignancies. However, its role in lymphoid malignancies has not been fully clarified.
Shahab Uddin   +6 more
doaj   +1 more source

Derepressing of STAT3 and USP7 contributes to resistance of DLBCL to EZH2 inhibition

open access: yesHeliyon, 2023
Diffuse large B-cell lymphoma is the most common subtype of lymphoma, representing ∼25 % of non-Hodgkin lymphoid malignancies. EZH2 is highly expressed in Diffuse large B-cell lymphoma and ∼22 % of patients contain EZH2 mutations.
Chenyun He   +3 more
doaj   +1 more source

The small FOXP1 isoform predominantly expressed in activated B cell-like diffuse large B-cell lymphoma and full-length FOXP1 exert similar oncogenic and transcriptional activity in human B cells

open access: yesHaematologica, 2017
The forkhead transcription factor FOXP1 is generally regarded as an oncogene in activated B cell-like diffuse large B-cell lymphoma. Previous studies have suggested that a small isoform of FOXP1 rather than full-length FOXP1, may possess this oncogenic ...
Martine van Keimpema   +8 more
doaj   +1 more source

Retrospective Analysis of Pemetrexed-based Chemotherapy Regimens on Mid-elderly Non-Hodgkin's Lymphoma

open access: yesZhongliu Fangzhi Yanjiu, 2020
Objective To analyze the safety and efficacy of pemetrexed-based chemotherapy on patients with mid-elderly non-Hodgkin's lymphoma. Methods We retrospectively reviewed the clinical data of patients with non-Hodgkin's lymphoma treated with pemetrexed-based
WEN Tingyu   +6 more
doaj   +1 more source

Non-Hodgkin’s Lymphoma in Buccal Vestibule -Case Report [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2014
Lymphomas are malignant neoplasms arising from lymphocytes B cell or T cell that affects mainly lymph nodes, spleen and other non hematopoietic tissues. They are classified as Hodgkin’s lymphoma (HL) and non-Hodgkin’s lymphoma (NHL). Diffuse large B-cell
Indira Reddy   +4 more
doaj   +1 more source

Case of Gastric Diffuse Large B-Cell Lymphoma

open access: yesCase Reports in Oncology, 2019
The gastrointestinal (GI) tract is the predominant site of extra nodal lymphoma involvement. In the United States (US), gastric lymphoma is the most common extra nodal site of lymphoma.
Usman A. Pirzada   +4 more
doaj   +1 more source

Burkitt lymphoma versus diffuse large B-cell lymphoma

open access: yesAnnals of Oncology, 2008
Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) represent distinct entities among aggressive B-cell non-Hodgkin lymphomas (B-NHLs) in the WHO classification [1]. According to the clinical setting of the occurrence, endemic, sporadic and immunodeficiency-associated BL can be distinguished as clinical variants.
A, Rosenwald, G, Ott
openaire   +2 more sources

Home - About - Disclaimer - Privacy